DE69113062T2 - Pharmazeutische zusammensetzungen. - Google Patents

Pharmazeutische zusammensetzungen.

Info

Publication number
DE69113062T2
DE69113062T2 DE69113062T DE69113062T DE69113062T2 DE 69113062 T2 DE69113062 T2 DE 69113062T2 DE 69113062 T DE69113062 T DE 69113062T DE 69113062 T DE69113062 T DE 69113062T DE 69113062 T2 DE69113062 T2 DE 69113062T2
Authority
DE
Germany
Prior art keywords
pharmaceutical compositions
active ingredient
sulphonamide
solvates
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69113062T
Other languages
English (en)
Other versions
DE69113062D1 (de
Inventor
Alain Emile Edouard Schaeffer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Glaxo Wellcome SA
Original Assignee
Laboratoires Glaxo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Glaxo SA filed Critical Laboratoires Glaxo SA
Publication of DE69113062D1 publication Critical patent/DE69113062D1/de
Application granted granted Critical
Publication of DE69113062T2 publication Critical patent/DE69113062T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69113062T 1990-12-21 1991-12-17 Pharmazeutische zusammensetzungen. Expired - Fee Related DE69113062T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909027827A GB9027827D0 (en) 1990-12-21 1990-12-21 Pharmaceutical compositions
PCT/EP1991/002425 WO1992011003A1 (en) 1990-12-21 1991-12-17 Pharmaceutical compositions
SG169594A SG169594G (en) 1990-12-21 1994-12-01 Effervescent pharmaceutical compositions containing a 5HT-receptor agonist

Publications (2)

Publication Number Publication Date
DE69113062D1 DE69113062D1 (de) 1995-10-19
DE69113062T2 true DE69113062T2 (de) 1996-02-01

Family

ID=26298162

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69113062T Expired - Fee Related DE69113062T2 (de) 1990-12-21 1991-12-17 Pharmazeutische zusammensetzungen.

Country Status (25)

Country Link
EP (1) EP0563094B1 (de)
JP (1) JP3425949B2 (de)
KR (1) KR100188172B1 (de)
AT (1) ATE127688T1 (de)
AU (1) AU654313B2 (de)
BE (1) BE1004182A3 (de)
CA (1) CA2099585C (de)
CH (1) CH684161A5 (de)
CZ (1) CZ281042B6 (de)
DE (1) DE69113062T2 (de)
DK (1) DK0563094T3 (de)
ES (1) ES2078727T3 (de)
FR (1) FR2670674B1 (de)
GB (2) GB9027827D0 (de)
GR (1) GR3017701T3 (de)
HK (1) HK18795A (de)
IE (1) IE914482A1 (de)
IL (1) IL100452A (de)
IT (1) IT1252599B (de)
MX (1) MX9102733A (de)
NZ (1) NZ241098A (de)
RU (1) RU2110992C1 (de)
SG (1) SG169594G (de)
WO (1) WO1992011003A1 (de)
ZA (1) ZA9110052B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2714064B1 (fr) * 1993-12-16 1996-03-08 Edmond Creppy Aspartame pour son application en tant que substance thérapeutiquement active.
GB0129117D0 (en) * 2001-12-05 2002-01-23 Glaxo Group Ltd Pharmaceutical composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
IE59106B1 (en) * 1985-05-31 1994-01-12 Warner Lambert Co A therapeutic effervescent composition and a method of preparing the same
FR2593065B1 (fr) * 1986-01-22 1988-09-09 Smith Kline French Lab Couples effervescents, compositions effervescentes d'antagonistes h2 de l'histamine les contenant et leur preparation.
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
IL100452A (en) 1997-02-18
AU654313B2 (en) 1994-11-03
CZ281042B6 (cs) 1996-06-12
KR100188172B1 (ko) 1999-06-01
GR3017701T3 (en) 1996-01-31
EP0563094A1 (de) 1993-10-06
EP0563094B1 (de) 1995-09-13
CA2099585C (en) 2003-09-30
GB2250917B (en) 1994-10-26
JPH06503826A (ja) 1994-04-28
NZ241098A (en) 1993-07-27
DE69113062D1 (de) 1995-10-19
FR2670674A1 (fr) 1992-06-26
IE914482A1 (en) 1992-07-01
ATE127688T1 (de) 1995-09-15
ZA9110052B (en) 1992-10-28
WO1992011003A1 (en) 1992-07-09
GB9126957D0 (en) 1992-02-19
CZ122593A3 (en) 1994-02-16
BE1004182A3 (fr) 1992-10-06
GB2250917A (en) 1992-06-24
IL100452A0 (en) 1992-09-06
GB9027827D0 (en) 1991-02-13
ITRM910963A0 (it) 1991-12-20
MX9102733A (es) 1992-09-01
ES2078727T3 (es) 1995-12-16
AU9066591A (en) 1992-07-22
CH684161A5 (fr) 1994-07-29
SG169594G (en) 1995-04-28
CA2099585A1 (en) 1992-06-22
DK0563094T3 (da) 1995-12-04
IT1252599B (it) 1995-06-19
JP3425949B2 (ja) 2003-07-14
FR2670674B1 (fr) 1994-05-13
HK18795A (en) 1995-02-17
RU2110992C1 (ru) 1998-05-20
ITRM910963A1 (it) 1993-06-20

Similar Documents

Publication Publication Date Title
ITBO910024A1 (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.
DE69231965T2 (de) Pharmazeutische formulierungen
NO921835L (no) Fremgangsmaate for fremstilling av amidinofenylalaninderivat samt anvendelse derav
SE8700498L (sv) Nya farmakologiskt aktiva foreningar
ATE219377T1 (de) Neue galenische orale pharmazeutische formulierung
LU90234I2 (fr) Une combination comprenant de la lamivudine facultativement sous la forme d'un sel pharmaceutiquement acceptable et de la zidovudine
ITBO910113A1 (it) Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
DK0519820T3 (da) Matrixtablet, som muliggør længerevarende frigivelse af indapamid efter oral administration
SE8804628D0 (sv) New compounds
LV10267A (lv) Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai
IT9019112A1 (it) Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
DE69113062T2 (de) Pharmazeutische zusammensetzungen.
ES2164168T3 (es) Antagonistas de receptores de fibrinogeno que tienen residuos de beta-aminoacido sustituidos y composiciones farmaceuticas que comprenden los mismos.
ITMI912044A0 (it) Composizione farmaceutica solida per uso orale a base di dapiprazolo
NO950177D0 (no) Farmakologisk aktive erivater
IT9021021A0 (it) Composizioni farmaceutiche per la somministrazione orale di irudina
ES2032573T3 (es) Procedimiento de preparacion de derivados de 4,4-dimetil-tetrahidropir-2-ona.
UA27784C2 (uk) Шипуча фармацевтична композиція для орального введення
IT1211138B (it) Composto antiipertensivo procedimento per la sua preparazione e relative composizioni farmaceutiche.
ITPD920141A1 (it) Formulazioni farmaceutiche per la somministraziane orale di calcitonina
ATA172297A (de) Pharmazeutische orale zusammensetzung enthaltend fk506
ITBO910225U1 (it) Dispositivo per la realizzazione di modelli di protesi dentarie.
MX9101421A (es) Composiciones farmaceuticas que comprenden naproxen y sodio de naproxen e hidrocloruro de pseudoefedrina.
IT9051202V0 (it) Confezione usa e getta per l'igiene orale.
ES1019422Y (es) Dispositivo para la higiene dental.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee